Your browser doesn't support javascript.
loading
Tolerability and Efficacy of the Anticluster of Differentiation 47 Antibody Magrolimab Combined With Azacitidine in Patients With Previously Untreated AML: Phase Ib Results.
Daver, Naval G; Vyas, Paresh; Kambhampati, Suman; Al Malki, Monzr M; Larson, Richard A; Asch, Adam S; Mannis, Gabriel; Chai-Ho, Wanxing; Tanaka, Tiffany N; Bradley, Terrence J; Jeyakumar, Deepa; Wang, Eunice S; Sweet, Kendra; Kantarjian, Hagop M; Garcia-Manero, Guillermo; Komrokji, Rami; Xing, Guan; Ramsingh, Giridharan; Renard, Camille; Zeidner, Joshua F; Sallman, David A.
Afiliação
  • Daver NG; The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Vyas P; MRC Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom.
  • Kambhampati S; Sarah Cannon Cancer Institute, Kansas City, MO.
  • Al Malki MM; City of Hope National Medical Center, Duarte, CA.
  • Larson RA; University of Chicago, Chicago, IL.
  • Asch AS; Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK.
  • Mannis G; Stanford University, Stanford, CA.
  • Chai-Ho W; University of California Los Angeles, Los Angeles, CA.
  • Tanaka TN; University of California San Diego Moores Cancer Center, San Diego, CA.
  • Bradley TJ; Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL.
  • Jeyakumar D; University of California Irvine, Orange, CA.
  • Wang ES; Roswell Park Comprehensive Cancer Center, Buffalo, NY.
  • Sweet K; Moffitt Cancer Center, Tampa, FL.
  • Kantarjian HM; The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Garcia-Manero G; The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Komrokji R; Moffitt Cancer Center, Tampa, FL.
  • Xing G; Gilead Sciences, Inc, Foster City, CA.
  • Ramsingh G; Gilead Sciences, Inc, Foster City, CA.
  • Renard C; Gilead Sciences, Inc, Foster City, CA.
  • Zeidner JF; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC.
  • Sallman DA; Moffitt Cancer Center, Tampa, FL.
J Clin Oncol ; 41(31): 4893-4904, 2023 11 01.
Article em En | MEDLINE | ID: mdl-37703506

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Azacitidina / Leucemia Mieloide Aguda Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Azacitidina / Leucemia Mieloide Aguda Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article